AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets open in 8 hrs 33 mins

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
172.61-0.53 (-0.31%)
At close: 4:00PM EST
People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close173.14
Open172.33
Bid172.73 x 100
Ask176.76 x 200
Day's Range171.89 - 174.70
52 Week Range133.64 - 176.85
Volume2,206,839
Avg. Volume3,605,445
Market Cap127.39B
Beta1.67
PE Ratio (TTM)16.86
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.65%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Who Could Buy Bristol-Myers Squibb?
    Motley Fool7 hours ago

    Who Could Buy Bristol-Myers Squibb?

    Carl Icahn has reportedly bought shares in this big-cap biopharma, but Bristol-Myers Squibb might be too big and costly to win an acquirer.

  • American City Business Journals10 hours ago

    In 'groundbreaking' deal, Harvard Pilgrim negotiates contracts to save on two pricey drugs

    Harvard Pilgrim Health Care has negotiated new payment contracts with two pharmaceutical companies for expensive drugs, progressing a new kind of payment model that could save millions of dollars down the line. If not, the insurer receives a rebate from the pharmaceutical company, which trickles down into more stable premiums for members. “If you think about it, this is considered groundbreaking but it shouldn’t be,” said Michael Sherman, chief medical officer and senior vice president for health services at Harvard Pilgrim.

  • Motley Fool11 hours ago

    Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease

    In this Valentine's Day edition, Industry Focus explores cholesterol busters, heart surgery, and the latest in anticoagulants.